Company Profiles

driven by the PitchBook Platform

BioNano Genomics

Description

Developer of nanoscale imaging and analytic platforms that are designed to analyze DNA and other genome-related peptides and proteins. The company’s technology provides analysis of genomic, epigenomic and proteomic information with sensitivity at the single molecule level. Its products are used in genetic diagnostics, personalized medicine and biomedical research applications.

2003

Founded

PRIVATE

Status

51-200

Employees

Series C

Latest Deal Type

$68.4M

Latest Deal Amount

$109M

Total Amount Raised

Description

Developer of nanoscale imaging and analytic platforms that are designed to analyze DNA and other genome-related peptides and proteins. The company’s technology provides analysis of genomic, epigenomic and proteomic information with sensitivity at the single molecule level. Its products are used in genetic diagnostics, personalized medicine and biomedical research applications.

Website:

www.bionanogenomics.com

Formerly Known As

BioNanomatrix

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Discovery Tools (Healthcare)

Other Industries

Diagnostic Equipment

Primary Office

9640 Towne Centre Drive Suite 100 San Diego, CA 92121United States +1 (858) 888-7600
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore BioNano Genomics's full profile, request a free trial.

BioNano Genomics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

BioNano Genomics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

BioNano Genomics Investors (11)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
21VenturesVenture CapitalMinority000 0000000 0000
Battelle VenturesVenture CapitalMinority000 0000000 0000
Ben Franklin Technology Partners of Southeastern PennsylvaniaVenture CapitalMinority000 0000000 0000
Domain AssociatesVenture CapitalMinority000 0000000 0000
Federated Kaufmann FundMutual FundMinority000 0000000 0000
21Ventures Venture Capital
Battelle Ventures Venture Capital
Ben Franklin Technology Partners of Southeastern Pennsylvania Venture Capital
Domain Associates Venture Capital
Federated Kaufmann Fund Mutual Fund

BioNano Genomics Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Han Cao Ph.DFounder & Chief Scientific Officer
Todd Dickinson Ph.DVice President, Global Commercial Operations
Mike WardVice President, Corporate Development
Erik Holmlin Ph.DPresident, Board Member & Chief Executive Officer
Fedor Trintchouk Ph.DDirector, Instrument Development
Han Cao Ph.D Founder & Chief Scientific Officer
Todd Dickinson Ph.D Vice President, Global Commercial Operations
Mike Ward Vice President, Corporate Development
Erik Holmlin Ph.D President, Board Member & Chief Executive Officer
Fedor Trintchouk Ph.D Director, Instrument Development

BioNano Genomics Board Members (4)

NameRepresentingRoleSinceContact
Info
Brian Halak Ph.DDomain AssociatesPartner000 0000
Campbell Murray MDNovartis Venture FundsManaging Director000 0000
Daqing Cai Ph.DLegend CapitalPartner & Executive Director000 0000
David Barker Ph.DSelfBoard Member000 0000
Brian Halak Ph.D Partner Domain Associates
Campbell Murray MD Managing Director Novartis Venture Funds
Daqing Cai Ph.D Partner & Executive Director Legend Capital
David Barker Ph.D Board Member Self
Request full access to PitchBook